Rankings
▼
Calendar
CRDF (Cardiff Oncology, Inc.) Stock Financials & Earnings | Market Cap Arena
CRDF
Cardiff Oncology, Inc.
Mkt Cap
$139M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$593,000
Net Income (TTM)
-$46M
EPS (TTM)
-$0.77
Free Cash Flow (TTM)
-$38M
Gross Margin
-1890.4%
Op. Margin
-8256.3%
Net Margin
-7732.2%
FCF Margin
-6402.5%
P/S Ratio (TTM)
234.6x
P/E Ratio (TTM)
—
YoY Rev Growth
-13.3%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$83K
$83K
-$12M
Q2 23
$108K
$108K
-$12M
Q3 23
$141K
$34K
-$11M
Q4 23
$156K
$53K
-$10M
Q1 24
$205K
$103K
-$11M
Q2 24
$163K
$58K
-$13M
Q3 24
$165K
-$9M
-$13M
Q4 24
$151K
$151K
-$13M
Q1 25
$109K
$109K
-$14M
Q2 25
$121K
-$11M
-$15M
Q3 25
$120K
$120K
-$12M
Q4 25
$243K
$20K
-$8M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
352.2x
—
Q2 23
337.7x
—
Q3 23
302.4x
—
Q4 23
285.1x
—
Q1 24
228.1x
—
Q2 24
209.2x
—
Q3 24
201.9x
—
Q4 24
203.4x
—
Q1 25
236.6x
—
Q2 25
254.8x
—
Q3 25
277.7x
—
Q4 25
234.6x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$9M
-$9M
Q2 23
-$7M
-$7M
Q3 23
-$8M
-$8M
Q4 23
-$7M
-$7M
Q1 24
-$8M
-$8M
Q2 24
-$9M
-$9M
Q3 24
-$10M
-$10M
Q4 24
-$10M
-$10M
Q1 25
-$13M
-$13M
Q2 25
-$8M
-$8M
Q3 25
-$11M
-$11M
Q4 25
-$6M
-$6M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$8K
Q2 23
$251K
Q3 23
$315K
Q4 23
$8K
Q1 24
$80K
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$26K
Q3 25
$18K
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+12.2%
+8.9%
Q2 23
+18.7%
+16.9%
Q3 23
+51.6%
+20.6%
Q4 23
+21.9%
+10.2%
Q1 24
+147.0%
-8.2%
Q2 24
+50.9%
+3.2%
Q3 24
+17.0%
+16.5%
Q4 24
-3.2%
+21.3%
Q1 25
-46.8%
+30.1%
Q2 25
-25.8%
+17.2%
Q3 25
-27.3%
-5.3%
Q4 25
+60.9%
-36.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$1M
1281.9%
Q2 23
$2M
1463.9%
Q3 23
$955K
677.3%
Q4 23
$909K
582.7%
Q1 24
$1M
548.3%
Q2 24
$1M
723.3%
Q3 24
$1M
759.4%
Q4 24
$1M
797.4%
Q1 25
$1M
1252.3%
Q2 25
$2M
1390.9%
Q3 25
$1M
1153.3%
Q4 25
$1M
518.9%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$9M
$3M
—
Q2 23
$8M
$4M
$584K
Q3 23
$8M
$2M
$536K
Q4 23
$8M
$4M
—
Q1 24
$8M
$3M
—
Q2 24
$9M
$3M
$459K
Q3 24
$10M
—
—
Q4 24
$10M
$3M
—
Q1 25
$10M
$4M
—
Q2 25
$12M
—
—
Q3 25
$8M
$4M
—
Q4 25
$5M
$4M
—
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$15M
$82M
$97M
Q2 23
$19M
$70M
$89M
Q3 23
$15M
$66M
$81M
Q4 23
$22M
$53M
$75M
Q1 24
$19M
$49M
$67M
Q2 24
$26M
$35M
$60M
Q3 24
$13M
$45M
$58M
Q4 24
$51M
$40M
$92M
Q1 25
$24M
$56M
$80M
Q2 25
$11M
$60M
$71M
Q3 25
$10M
$50M
$61M
Q4 25
$17M
$41M
$58M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
45M
+0.0%
Q2 23
45M
+0.0%
Q3 23
45M
+0.0%
Q4 23
45M
+0.0%
Q1 24
45M
+0.0%
Q2 24
45M
+0.3%
Q3 24
47M
+4.6%
Q4 24
48M
+1.7%
Q1 25
48M
+0.0%
Q2 25
67M
+39.6%
Q3 25
67M
+0.5%
Q4 25
67M
-0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$56K
5
FY 15
$4K
72
FY 16
$7K
53
FY 17
$30K
17
FY 18
$29K
13
FY 19
$17K
14
FY 20
$31K
12
FY 21
$16K
23
FY 22
$15K
26
FY 23
$15K
32
FY 24
$21K
33
FY 25
$19K
31
marketcaparena.com